impact of the revised eln-2017 aml recommendations
Published 1 year ago • 73 plays • Length 1:36Download video MP4
Download video MP3
Similar videos
-
5:15
impact of mmrd and eln genetic classification in outcomes for patients with aml underoging allohct
-
2:26
impact of allelic state on os in tp53-mutant aml and hr-mds
-
1:45
the impact of secondary-type mutations in npm1-mutated aml
-
4:51
the impact of idh mutated clones in npm1 aml
-
3:21
the prognostic impact of flt3-itd and flt3-tkd in npm1-mutated aml
-
3:18
the impact of secondary aml mutations on the prognosis of patients with npm1-mutated aml
-
3:07
the impact of blast enumeration & co-occurring myelodysplasia-related mutations in npm1-mutated aml
-
3:10
novel aml treament approaches
-
11:06
how could new treatment options improve outcomes in flt3-mutated aml?
-
55:57
defining regeneration and non-regeneration at a cellular and molecular level
-
2:26
early car-t results for cd33 positive aml using prgn-3006 ultracar-t | david sallman | ash 2021 #aml
-
1:06
investigating the molecular and clinical features of flt3-jmd mutations in aml
-
9:20
iwal 2018: a plethora of new drugs & their impact on trial design
-
3:37
the future of aml treatment
-
7:54
does the mutational profile impact outcomes following transplant?
-
3:19
an overview of novel treatment approaches in tp53-mutated aml
-
1:54
fusion-aml-001: molecular changes associated with azacitidine & durvalumab in tp53m aml and hr-mds
-
4:31
mpns at eha 2020: what to look out for
-
5:35
clinical and prognostic significance of aberrant t-cell marker expression in aml
-
1:21
intensive therapy of older aml
-
2:35
quizartinib for frontline flt3-itd aml: updated results from the quantum-first trial
-
3:18
the molecular impact of runx1 mutations in aml